跳至主要内容
临床试验/NCT06735924
NCT06735924进行中(未招募)不适用

Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2023年4月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
28
试验地点
2
主要终点
estimated endogenous oxalate synthesis rate

研究概览

简要总结

This study aims to determine the daily rate of endogenous synthesis of oxalate using fasted urine collection and a low-oxalate controlled diet in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

详细描述

Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use a low-oxalate controlled diet, repeat fasted urine collections and 24-hr urine collections on a low-oxalate diet, to determine the daily rate of endogenous oxalate synthesis in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >18 years
  • History of MASLD, with liver fat content > 5%
  • Normal kidney function
  • Stable medication for at least 1 month for diabetes mellitus if any
  • Willingess to ingest fixed diets and stop dietary supplements for the study and come to UAB for visits

排除标准

  • Age < 18 years
  • Inaccurate 24-hour urine collections
  • Liver fat content <5%
  • Liver cirrhosis
  • Evidence of other chronic liver disease, viral hepatitis
  • history of alcoholism within 2 years of enrollment
  • Contra-indication to Magnetic Resonance Imaging
  • Chronic kidney disease with estimated Glomerular Filtration rate < 60 ml/min/1.73m2
  • Type 1 Diabetes Mellitus or treatment with insulin
  • Uncontrolled diabetes
  • Pregnancy, lactation or intention to be
  • Uncontrolled hypertension
  • Use of weight loss medication, SGLT2 inhibitors, GLP-1 receptor agonists, osteoporosis medication, chronic NSAID
  • History of gastric or intestinal surgery or resection that could potentially alter oxalate absorption
  • Chronic fat malabsorption
  • Use of immunosuppressive medications
  • Known immuno-compromised status
  • Active malignancy or treatment for malignanacy within the last 12 months

研究组 & 干预措施

Estimation of endogenous oxalate production

Experimental

Fasted hourly urine collections after equilibration on a low-oxalate diet

干预措施: Low-oxalate fixed diet (Dietary Supplement)

结局指标

主要结局

estimated endogenous oxalate synthesis rate

时间窗: 1 day

Average fasted hourly urinary oxalate excretion rate normalized to urinary creatinine excretion (mg oxalate / g urinary creatinine)

次要结局

  • Urinary Oxalate excretion(2 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyle D. Wood

Principal Investigator

University of Alabama at Birmingham

研究点 (2)

Loading locations...

相似试验